# Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference
Ticker: LQDA
Company: Liquidia Corporation
Source: Liquidia Corporation
Published: 2026-06-25 13:46 EST
Original Source URL: https://www.liquidia.com
## Summary

MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company’s business in a fireside chat at the

## Article Body
MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company’s business in a fireside chat at the
## Recent Company News
- 2026-06-25 13:46 EST — [Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions](https://biopharmsignal.com/news/LQDA/liquidia-announces-poster-presentations-at-the-pha-2026-international-ph-conference-and-scientific-sessions) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index](https://biopharmsignal.com/news/LQDA/liquidia-corporation-announces-inclusion-in-the-sandp-smallcap-600r-index) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results) — Source: Liquidia Corporation
- 2026-06-25 13:46 EST — [Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-third-quarter-2025-financial-results-and-provides-corporate-update) — Source: Liquidia Corporation
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)